Cardiomedics, Inc.
Company applies for Medicare coverage of heart failure treatment
Published in Biotech Law Weekly, August 5th, 2005
There are an estimated 2.5 million heart failure patients in Classes II, III and IV in the United States, 400,000 of whom are due each year, and 500,000 new heart failure patients are diagnosed annually. The treatment of heart failure is the largest single cost to Medicare, $40 billion per year.
Cardiomedics has requested that Medicare coverage of ECP for the treatment of heart failure be limited to the use of ECP devices...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2005-08-05)
More Articles from Biotech Law Weekly
- Azee, Inc.
Genomics company completes agreement for small molecule technology - Bavarian Nordic A/S
U.S. patent granted for modified virus ankara - Blue Cross and Blue Shield of Minnesota
Seven healthcare benefit plans form alliance to offer regional Medicare products - Braintree Laboratories, Inc.
Company increases presence in the pediatric market with Axid acquisition - Collaborations
Strategic alliance formed to help Medicare beneficiaries with drug plans - EB Rubinstein Associates
Profits unlikely for vendors to Medicare's competitive acquisition program - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
